VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $48,000 | -22.6% | 3,000 | 0.0% | 0.01% | -16.7% |
| Q4 2017 | $62,000 | +44.2% | 3,000 | 0.0% | 0.01% | +50.0% |
| Q3 2017 | $43,000 | -17.3% | 3,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $52,000 | +57.6% | 3,000 | 0.0% | 0.01% | +50.0% |
| Q1 2017 | $33,000 | -55.4% | 3,000 | 0.0% | 0.00% | -55.6% |
| Q4 2016 | $74,000 | 0.0% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $74,000 | +23.3% | 3,000 | 0.0% | 0.01% | +12.5% |
| Q2 2016 | $60,000 | -55.9% | 3,000 | +290.6% | 0.01% | -61.9% |
| Q3 2015 | $136,000 | -22.3% | 768 | -2.7% | 0.02% | -16.0% |
| Q2 2015 | $175,000 | -11.6% | 789 | -19.9% | 0.02% | -13.8% |
| Q1 2015 | $198,000 | +16.5% | 985 | -17.4% | 0.03% | +11.5% |
| Q4 2014 | $170,000 | -46.7% | 1,192 | -51.1% | 0.03% | -48.0% |
| Q3 2014 | $319,000 | +18.6% | 2,439 | +6.5% | 0.05% | +28.2% |
| Q2 2014 | $269,000 | +61.1% | 2,291 | +77.0% | 0.04% | +69.6% |
| Q1 2014 | $167,000 | +15.2% | 1,294 | +19.4% | 0.02% | +4.5% |
| Q4 2013 | $145,000 | +61.1% | 1,084 | +25.2% | 0.02% | +57.1% |
| Q3 2013 | $90,000 | +20.0% | 866 | -0.7% | 0.01% | -63.2% |
| Q2 2013 | $75,000 | +13.6% | 872 | -0.3% | 0.04% | +2.7% |
| Q1 2013 | $66,000 | -16.5% | 875 | -9.8% | 0.04% | -40.3% |
| Q2 2012 | $79,000 | +5.3% | 970 | +11.2% | 0.06% | 0.0% |
| Q1 2012 | $75,000 | – | 872 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |